Abbott's Assert-IQ offers the world's longest battery life† for an insertable cardiac monitor (ICM) The latest addition to Abbott's portfolio of connected health devices, the Assert-IQ ICM offers long ...

Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...

Insertable cardiac monitors detected a higher incidence of atrial fibrillation in patients with prior ischemic stroke over a three-year period than standard medical monitoring methods, according to ...

Abbott Laboratories landed CE mark for two versions of its Assert-IQ insertable cardiac monitor (ICM), one with a three-year battery life, the other lasting six years. Designed for long-term remote ...

Jennifer Adamy, a 43-year-old cardiac nurse living in New Smyrna Beach, Florida, was very familiar with the signs of heart problems. So, when she started experiencing symptoms of irregular heart ...

Abbott has secured a CE mark approval in Europe for its long-term insertable cardiac monitor, designed to help monitor a patient’s heart rhythms remotely for up to six years. The Bluetooth-equipped ...

Abbott Laboratories, Inc. ABT recently announced the receipt of CE Mark in Europe for its Assert-IQ insertable cardiac monitor (ICM). The ICM offers physicians a new option for diagnostic evaluation ...

Please provide your email address to receive an email when new articles are posted on . Remote reprogramming for implantable cardiac devices was associated with an improvement in clinic workflow.

The FDA has cleared Abbott’s Confirm Rx Insertable Cardiac Monitor (ICM), an implantable device that continuously tracks patients’ heart rhythms and sends the data to a smartphone app via Bluetooth.

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings HONORABLE MENTION: For those with cardiovascular conditions, keeping tabs on ...